UBS Group
MATN

UBS Group’s Mateon Therapeutics, Inc. MATN Stock Holding History

UBS Group’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,188
Closed -$1K – 7164
2016
Q3 		$1K Sell
1,188
-7,965
-87% -$6.71K ﹤0.01% 6639
2016
Q2 		$6K Buy
+9,153
New +$6K ﹤0.01% 6182